文献速递性腺与生殖内分泌肥胖与代谢综合征

TLR4相关IRF-7和NFκB信号作为雄激素与二甲双胍活性及PCOS子宫内膜细胞因子合成的分子链接

TLR4-Associated IRF-7 and NFκB Signaling Act as a Molecular Link Between Androgen and Metformin Activities and Cytokine Synthesis in the PCOS Endometrium.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究探讨PCOS子宫内膜细胞因子合成与炎症机制,发现PCOS患者子宫内膜雄激素受体、TLR2/4介导的IRF-7和NFκB信号激活及细胞因子产生显著增加;体外实验表明双氢睾酮(DHT)通过雄激素受体增强TLR4/IRF-7/NFκB信号和干扰素产生,氟他胺可阻断,二甲双胍则抑制该通路及细胞因子表达。

要点

  • PCOS子宫内膜存在雄激素驱动的TLR4/IRF-7/NFκB信号激活和炎症因子增加
  • DHT通过雄激素受体上调TLR4/IRF-7/NFκB通路及IFNα/IFNγ,氟他胺可逆转
  • 二甲双胍可抑制PCOS子宫内膜IRAK4/IRF-7/NFκB通路及IFNγ、TNFα表达

核心结论

  • PCOS患者子宫内膜细胞因子合成和炎症增加与雄激素诱导的TLR4/IRF-7/NFκB信号相关,二甲双胍可抑制该通路。

研究设计与样本

  • 研究纳入非PCOS患者17例和PCOS患者22例,采集子宫内膜活检样本(增生期或增生期伴增生),并进行体外药物干预实验。

主要发现

  • PCOS患者子宫内膜雄激素受体、TLR2和TLR4介导的IRF-7和NFκB信号激活、细胞因子产生及炎症显著高于非PCOS患者(伴或不伴子宫内膜增生)。
  • 体外实验中,DHT增强雄激素受体、TLR4、IRF-7和p-NFκB p65蛋白表达,并增加IFNα和IFNγ水平;氟他胺可消除DHT对IRF-7、p-NFκB p65和IFN的影响。
  • 17β-雌二醇(E2)降低p-IRF-7表达,但对TLR介导的IRF7和NFκB信号或细胞因子蛋白水平影响不大;二甲双胍单独或联合E2抑制IRAK4、p-IRF-7、IRF-7、IKKα、p-NFκB p65、IFNγ和TNFα蛋白表达。

临床怎么用

  • 二甲双胍可能通过抑制子宫内膜TLR4/IRF-7/NFκB信号通路减轻PCOS相关子宫内膜炎症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Low-grade chronic inflammation is commonly seen in polycystic ovary syndrome (PCOS) patients with elevated levels of inflammatory cytokines in the endometrium. OBJECTIVE: This work aimed to increase the limited understanding of the mechanisms underlying cytokine synthesis and increased endometrial inflammation in PCOS patients. METHODS: Endometrial biopsy samples were collected from non-PCOS (n = 17) and PCOS (n = 22) patients either during the proliferative phase of the menstrual cycle or with hyperplasia. Endometrial explants were prepared from PCOS patients and underwent pharmacological manipulation in vitro. The expression and localization of toll-like receptor 2 (TLR2)/4, key elements of innate immune signal transduction and nuclear factor κB (NFκB) signaling pathways, and multiple cytokines were comprehensively evaluated by Western blotting, immunohistochemistry, and immunofluorescence in endometrial tissues. RESULTS: We demonstrated the distribution of protein expression and localization associated with the significantly increased androgen receptor, TLR2, and TLR4-mediated activation of interferon regulatory factor-7 (IRF-7) and NFκB signaling, cytokine production, and endometrial inflammation in PCOS patients compared to non-PCOS patients with and without endometrial hyperplasia. In vitro experiments showed that 5-dihydrotestosterone (DHT) enhanced androgen receptor, TLR4, IRF-7, and p-NFκB p65 protein expression along with increased interferon α (IFNα) and IFNɣ abundance. The effects of DHT on IRF-7, p-NFκB p65, and IFN abundance were abolished by flutamide, an antiandrogen. Although 17β-estradiol (E2) decreased p-IRF-7 expression with little effect on TLR-mediated IRF7 and NFκB signaling or on cytokine protein levels, exposure to metformin alone or in combination with E2 suppressed interleukin-1 receptor-associated kinase 4 (IRAK4), p-IRF-7, IRF-7, IκB kinase α (IKKα), p-NFκB p65, IFNɣ, and tumor necrosis factor α protein expression. CONCLUSION: Cytokine synthesis and increased endometrial inflammation in PCOS patients are coupled to androgen-induced TLR4/IRF-7/NFκB signaling, which is inhibited by metformin treatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hu M, Zhang Y, Li X, et al. TLR4-Associated IRF-7 and NFκB Signaling Act as a Molecular Link Between Androgen and Metformin Activities and Cytokine Synthesis in the PCOS Endometrium. J Clin Endocrinol Metab. 2021. PMID: 33382900. doi:10.1210/clinem/dgaa951

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。